Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis

Arthritis and Rheumatism

Volumn 42, Issue 5, 1999, Pages 930-941

  Rajkumar, Vineeth S ^a   Sundberg, Christian ^b   Abraham, David J ^a   Rubin, Kristofer ^c   Black, Carol M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAYNAUD PHENOMENON; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; PERICYTES; RAYNAUD DISEASE; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0032929924     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1     Document Type: Article

References (61)

1. Wigley FM, Flavahan NA. Raynaud's phenomenon. Rheum Dis Clin North Am 1996;22:765-81.
2. Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990;16:11-30.
3. Black CM. The aetiopathogenesis of systemic sclerosis: thick skin-thin hypotheses - the Parkes Weber Lecture 1994. J R Coll Physicians Lond 1995;29:119-30.
4. Jimenez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J 1986;237:837-43.
5. Krieg T, Perlish JS, Mauch C, Fleischmajer R. Collagen synthesis by scleroderma fibroblasts. Ann N Y Acad Sci 1985;460:375-86.
6. Buckingham RB, Prince RK, Rodnan GP. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan. J Lab Clin Med 1983;101: 659-69.
7. Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
8. Kohler N, Lipton A. Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 1974;87:297-301.
9. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 1974;71:1207-10.
10. D'Amore PA, Smith SR. Growth factor effects on cells of the vascular wall: a survey. Growth Factors 1993;8:61-75.
11. Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdin B. Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invest 1993;91:2065-75.
12. Gay S, Jones RE Jr, Huang GQ, Gay RE. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 1989; 92:301-3.
13. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986;46:155-69.
14. Raines EW, Bowen-Pope DF, Ross R, Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. Heidelberg: Springer Verlag; 1990.
15. Terracio L, Ronnstrand L, Tingstrom A, Rubin K, Claesson-Welsh L, Funa K, et al. Induction of platelet-derived growth factor receptor expression in smooth muscle cells and fibroblasts upon tissue culturing. J Cell Biol 1988;107:1947-57.
16. Eriksson A, Siegbahn A, Westermark B, Heldin CH, Claesson-Welsh L. PDGF alpha-and beta-receptors activate unique and common signal transduction pathways. EMBO J 1992;11:543-50.
17. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109:429-40.
18. Pierce GF, Mustoe TA, Senior RM, Reed J, Griffin GL, Thomason A, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988;167:974-87.
19. Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M, Westermark B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci U S A 1993;90:393-7.
20. Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci U S A 1987;84:7696-700.
21. Reuterdahl C, Tingstrom A, Terracio L, Funa K, Heldin CH, Rubin K. Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synovium. Lab Invest 1991;64:321-9.
22. Rubin K, Tingstrom A, Hansson GK, Larsson E, Ronnstrand L, Klareskog L, et al. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet 1988;1:1353-6.
23. Sundberg C, Ljungstrom M, Lindmark G, Gerdin B, Rubin K. Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol 1993;143:1377-88.
24. Sundberg C, Ivarsson M, Gerdin B, Rubin K. Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 1996;74: 1-15.
25. Chaudhry A, Papanicolaou V, Oberg K, Heldin CH, Funa K. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system. Cancer Res 1992; 52:1006-12.
26. Heldin P, Pertoft H, Nordlinder H, Heldin CH, Laurent TC. Differential expression of platelet-derived growth factor alpha-and beta-receptors on fat-storing cells and endothelial cells of rat liver. Exp Cell Res 1991;193:364-9.
27. Fellstrom B, Klareskog L, Larsson E, Tufveson G, Wahlberg J, Ronnstrand L, et al. Tissue distribution of macrophages, class II transplantation antigens, and receptors for platelet-derived growth factor in normal and rejected human kidneys. Transplant Proc 1987;19:3625-7.
28. Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997;277:242-5.
29. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994; 8:1888-96.
30. Sims DE. The pericyte - a review. Tissue Cell 1986;18:153-74.
31. Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 1987;105: 1455-62.
32. Crocker DJ, Murad TM, Geer JC. Role of the pericyte in wound healing: an ultrastructural study. Exp Mol Pathol 1970;13:51-65.
33. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996;32:687-98.
34. Brighton CT, Lorich DG, Kupcha R, Reilly TM, Jones AR, Woodbury RA II. The pericyte as a possible osteoblast progenitor cell. Clin Orthop 1992:287-99.
35. Ivarsson M, Sundberg C, Farrokhnia N, Pertoft H, Rubin K, Gerdin B. Recruitment of type I collagen producing cells from the microvasculature in vitro. Exp Cell Res 1996;229:336-49.
36. Diaz-Flores L, Valladares F, Gutierrez R, Varela H. The role of the pericytes of the adventitial microcirculation in the arterial intimai thickening. Histol Histopathol 1990;5:145-53.
37. Masuda H, Fukumoto M, Hirayoshi K, Nagata K. Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1994;94:2481-8.
38. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 1994;19:1262-71.
39. Knittel T, Schuppan D, Meyer zum Buschenfelde KH, Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (ito) cells in vitro. Gastroenterology 1992;102:1724-35.
40. Klareskog L, Gustafsson R, Scheynius A, Hällgren R. Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum 1990;33:1534-41.
41. Yamakage A, Kikuchi K, Smith EA, Leroy EC, Trojanowska M. Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in sclcroderma fibroblasts. J Exp Med 1992;175:1227-34.
42. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
43. Leroy EC, Medsger TA Jr. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485-8.
44. McCarty GA, Valencia DW, Fritzler MJ. Antinuclear antibodies: contemporary techniques and clinical applications to connective tissue diseases. New York: Oxford University Press; 1984.
45. Ronnstrand L, Terracio L, Claesson-Welsh L, Heldin CH, Rubin K. Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptor. J Biol Chem 1988;263:10429-35.
46. Heldin CH, Backstrom G, Ostman A, Hammacher A, Ronnstrand L, Rubin K, et al. Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J 1988;7:1387-93.
47. Tingstrom A, Reuterdahl C, Lindahl P, Heldin CH, Rubin K. Expression of platelet-derived growth factor-beta receptors on human fibroblasts: regulation by recombinant platelet-derived growth factor-BB, IL-1, and tumor necrosis factor-alpha. J Immunol 1992;148:546-54.
48. Ziai MR, Imberti L, Nicotra MR, Badaracco G, Segatto O, Natali PG, et al. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen. Cancer Res 1987;47:2474-80.
49. Schlingemann RO, Rietveld FJ, de Waal RM, Ferrone S, Ruiter DJ. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol 1990;136:1393-405.
50. Schlingemann RO, Rietveld FJ, Kwaspen F, van de Kerkhof PC, de Waal RM, Ruiter DJ. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 1991;138: 1335-47.
51. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer: recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995;95:859-73.
52. Verbeek MM, Otte-Holler I, Wesseling P, Ruiter DJ, de Waal RM. Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am J Pathol 1994;144:372-82.
53. Shiraishi T, Morimoto S, Itoh K, Sato H, Sugihara K, Onishi T, et al. Radioimmunoassay of human platelet-derived growth factor using monoclonal antibody toward a synthetic 73-97 fragment of its B-chain. Clin Chim Acta 1989;184:65-74.
54. Lindmark G, Sundberg C, Glimelius B, Pahlman L, Rubin K, Gerdin B. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer. Lab Invest 1993;69:682-9.
55. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 1985;52:71-6.
56. Sundberg C, Branting M, Gerdin B, Rubin K. Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma: transfer of platelet-derived growth factor-AB/BB to stromal cells. Am J Pathol 1997;151:479-92.
57. Kischer CW, Pindur J, Krasovitch P, Kischer E. Characteristics of granulation tissue which promote hypertrophic scarring. Scanning Microsc 1990;4:877-87.
58. Pierce GF, van de Berg J, Rudolph R, Tarpley J, Mustoe TA. Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol 1991;138: 629-46.
59. Diaz-Flores L, Gutierrez R, Varela H. Behavior of postcapillary venule pericytes during postnatal angiogenesis. J Morphol 1992; 213:33-45.
60. Kahari VM, Sandberg M, Kalimo H, Vuorio T, Vuorio E. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol 1988;90:664-70.
61. Sorkin A, Westermark B, Heldin CH, Claesson-Welsh L. Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF beta-receptor. J Cell Biol 1991;112:469-78.